Skip to main content
Trending storyContinuously updated

Yosemite's second fund tops $350M target, Reed Jobs says

1 reports1 report sources3 hours agoUpdate

Get up to speed on this story

AI Summary

Yosemite, the oncology-focused venture capital firm founded by Reed Jobs, has surpassed the $350 million target for its second fund, Jobs said. Jobs also said GLP-1 drugs could help prevent cancer by reducing obesity. The firm's focus is cancer investing; the fund size figure comes from Jobs and was not independently confirmed in the report.

AI-generated from reports · 2 hours agoUpdate

Latest updatesOct 28 21:33
Reed Jobs Says GLP-1 Drugs Could Help Fight Cancer

Report timeline

Follow the reports to understand different sides of the story.

Oct 28
  1. Fortune Term Sheet
    Reed Jobs Says GLP-1 Drugs Could Help Fight Cancer

    Reed Jobs, founder of oncology VC firm Yosemite, said GLP-1 drugs could help prevent cancer by reducing obesity.

Trend for this story

Not enough continuous observation data yet; trend chart is not drawn for now.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing